Form 4: Evolent Health CFO John Paul Johnson Reports Changes in Beneficial Ownership

John Paul Johnson, CFO of Evolent Health, reports acquisition and disposal of Class A Common Stock related to restricted stock units.

Summary

• On March 1, 2024, John Paul Johnson, CFO of Evolent Health, acquired 12,123 shares of Class A Common Stock as restricted stock units.
• These securities vest at a rate of 34% on March 1, 2025, and 33% on March 1, 2026, and March 1, 2027.
• On March 1 and 2, 2024, Johnson disposed of 11,213 and 9,020 shares of Class A Common Stock, respectively, at a price of $34.41 per share to satisfy tax withholding obligations.
• Following these transactions, Johnson beneficially owns 215,900 shares of Class A Common Stock.

Sentiment

Score: 6

Explanation: The document reflects routine transactions related to executive compensation. It is neither overtly positive nor negative, but rather informational.

Positives

• The grant of restricted stock units to the CFO aligns his interests with those of the shareholders.
• Continued stock ownership by a key executive demonstrates confidence in the company's future.

Negatives

• The disposal of shares to cover tax obligations, while common, slightly reduces the CFO's holdings.

Risks

• Future vesting events could lead to further stock disposals to cover tax liabilities, potentially creating selling pressure.

Future Outlook

The document does not contain specific forward-looking statements, but it outlines the vesting schedule for the restricted stock units.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The vesting of restricted stock units is a common compensation practice.

Comparison to Industry Standards

• Stock-based compensation is a common practice among publicly traded companies, particularly in the healthcare and technology sectors.
• Companies like UnitedHealth Group (UNH) and CVS Health (CVS) also utilize stock options and restricted stock units as part of their executive compensation packages.
• The vesting schedules and amounts granted to executives are typically benchmarked against peer companies to ensure competitiveness.

Stakeholder Impact

• Shareholders are informed about the CFO's transactions in company stock, promoting transparency.
• Employees may be indirectly affected by the company's financial performance, which is influenced by executive decisions and incentives.

Key Dates